AMENDMENT AND PREFERRED EXCHANGE AGREEMENTAmendment and Preferred Exchange Agreement • December 27th, 2023 • Evofem Biosciences, Inc. • Pharmaceutical preparations
This Amendment and Preferred Exchange Agreement (the “Agreement”) is entered into as of the date set forth on the signature pages below, by and among Evofem Biosciences, Inc., a Delaware corporation with offices located at 7770 Regents Road, Suite 113-618, San Diego CA 92122 (the “Company”) and the investor signatory hereto (the “Holder”), with reference to the following facts:
